Tamar GrossmanCEO at La Jolla LabsSpeaker
Agenda Sessions
Panel: The role of AI in RNA – Drug Discovery, Rare Diseases and Clinical Applications
, 4:30pmView SessionRapid Development and First-in-Human Treatment of GBFsen, a Patient-Specific Antisense Oligonucleotide Therapy for familial TDP-43 Amyotrophic Lateral Sclerosis
, 9:00amView Session
